News & Updates
Filter by Specialty:
Signs of heavy menstrual bleeding often missed; standardized criteria for assessment needed
20 Jan 2023
byJairia Dela Cruz
Healthcare professionals (HCPs) and women themselves may overlook the signs of heavy menstrual bleeding, with most HCPs failing to recognize the key indicators for bleeding disorders and perform assessments for patients with heavy menstrual bleeding, according to a study presented at ASH 2022.
Signs of heavy menstrual bleeding often missed; standardized criteria for assessment needed
20 Jan 2023
TNFα antagonists, non-TNF biologics both safe for treating IBD in cancer patients
20 Jan 2023
Tumour necrosis factor (TNF)-α antagonists show comparable safety as non-TNF biologics in the treatment of inflammatory bowel disease (IBD) in patients with active or recent cancer, as shown in a study.
TNFα antagonists, non-TNF biologics both safe for treating IBD in cancer patients
20 Jan 2023
POSEIDON: Dual ICIs plus chemo up survival in first-line mNSCLC
20 Jan 2023
byKanas Chan
Adding two immune checkpoint inhibitors, tremelimumab (T) and durvalumab (D), to platinum-based chemotherapy (CT) significantly improves overall survival (OS) and progression-free survival (PFS) vs CT alone in first-line treatment of metastatic non-small-cell lung cancer (mNSCLC), without causing a meaningful increase in toxicity, according to results of the phase III POSEIDON trial.
POSEIDON: Dual ICIs plus chemo up survival in first-line mNSCLC
20 Jan 2023
Total diet replacement shows promise for difficult-to-treat asthma
19 Jan 2023
A low-calorie total diet replacement program (Counterweight-Plus) is safe and improves asthma control and quality of life in patients with difficult-to-treat asthma and obesity, according to 16-week data from a recent study.
